Analyst Price Target is C$0.00
This price target is based on 0 analysts offering 12 month price targets for Dialogue Health Technologies in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a NaN upside from the last price of C$0.00.
Current Consensus is
N/A
The current consensus among 0 polled investment analysts is to n/a stock in Dialogue Health Technologies. This rating has held steady since February 2024, when it changed from a Hold consensus rating.
Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance program. Dialogue Technologies Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.
Read More